Cogentis Therapeutics

Private

Columbia, MarylandHealthcare & Life Scienceshttps://cogentistherapeutics.com/

Last Round

Grant

Apr 30, 2020

Total Funding Raised

$188,193

Company Overview

Cogentis Therapeutics is a biotechnology company that develops disease-modifying therapeutics for neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neurodegenerative diseasepeptide therapeuticdrug discoverybiotechCDK5Alzheimer's researchParkinson's treatmentpreclinical developmentdisease-modifying therapybiotech startupdrug pipelinepharma licensingneuroscience

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cogentis Therapeutics Comparables

Compare Cogentis Therapeutics with similar companies based on industry and business-model similarity.

Cogentis Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
4M Therapeutics	88%
Teitur Trophics	80%
Perha Pharmaceuticals	71%

View all Comparables

Cogentis Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 30, 2020
Accelerator	May 21, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Kent Werner

Co-founder and CEO

Founding Team

Cogentis Therapeutics Investors

Notable investors and investment history

Cogentis Therapeutics investors
Investor	Rounds
The Association for Frontotemporal Degeneration	Grant
MassChallenge Israel	Accelerator
Alzheimer's Drug Discovery Foundation	Grant

View all Investors

Cogentis Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cogentis Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cogentis Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersColumbia, Maryland

Employee Range4

Year Founded2015

Last FundingApr 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.